Skip to content


James Dale, MD

Dr. Dale is the Chief of Infectious Diseases and maintains an active research laboratory in the Coleman College of Medicine Building. His research activities are directed at understanding the basic mechanisms of group A streptococcal infections and their complications. This includes structure/function studies of streptococcal virulence determinants, normal and abnormal host immune responses to streptococcal antigens, the pathogenesis of acute rheumatic fever and rheumatic carditis, and the development of vaccines that will prevent group A streptococcal infections.

Kerry Cleveland, MD

Dr. Cleveland conducts clinical research projects dealing with antimicrobials in hospitalized patients and HIV therapeutic and prophylactic agents.

Harry Courtney, PhD

Dr. Courtney is an integral member of the bacterial pathogenesis research group of the Division. He is an independently funded investigator whose interests are in defining the molecular pathogenesis of group A streptococcal infections. Most recently he has performed studies to unravel the role of serum opacity factor in the pathogenesis of streptococcal infections, particularly those that may trigger acute poststreptococcal glomerulonephritis.

Michael Gelfand, MD

Dr. Gelfand is the senior member of the clinical infectious diseases program at the Methodist University Hospital and is involved in clinical research focusing on antibiotic trials and infections in immunocompromised hosts, including solid organ transplant recipients and neutropenic cancer patients.

Shirin Mazumder, MD

Dr. Mazumder is active in ambulatory and inpatient infectious disease services at the Methodist University Hospital and is involved in clinical research projects in both arenas.

John Norwood, MD

Dr. Norwood is the Director of the HIV/AIDS clinic at Regional One Medical Center and conducts investigator- and corporate-sponsored research protocols on HIV therapeutic and prophylactic agents.

Last Published: Jan 27, 2020